Therapeutic antibodies

Results: 49



#Item
1INTERNSHIP PROPOSAL Institute and Group: IBS group HIV and persistent human viruses Supervisor: Pascal Poignard Email: Research project title: Human monoclonal antibodies: a new therapeutic strategy

INTERNSHIP PROPOSAL Institute and Group: IBS group HIV and persistent human viruses Supervisor: Pascal Poignard Email: Research project title: Human monoclonal antibodies: a new therapeutic strategy

Add to Reading List

Source URL: www.labex-gral.fr

Language: English - Date: 2018-02-23 05:16:06
    2Visterra Acquires Exclusive Patent License for Monoclonal Antibodies against Dengue Virus from MIT – Expands Company’s Therapeutic Pipeline for Infectious Diseases – Cambridge, MA – December 2, 2013 – Visterra,

    Visterra Acquires Exclusive Patent License for Monoclonal Antibodies against Dengue Virus from MIT – Expands Company’s Therapeutic Pipeline for Infectious Diseases – Cambridge, MA – December 2, 2013 – Visterra,

    Add to Reading List

    Source URL: www.visterrainc.com

    Language: English - Date: 2017-10-03 19:39:42
      3EAP Reimbursement Criteria for Frequently Requested Drugs

      EAP Reimbursement Criteria for Frequently Requested Drugs

      Add to Reading List

      Source URL: www.health.gov.on.ca

      Language: English - Date: 2015-08-17 11:45:03
      424 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO Box

      24 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO Box

      Add to Reading List

      Source URL: www.nzma.org.nz

      Language: English - Date: 2016-05-25 01:37:50
      512 JulyGeraldine MacGibbon Senior Therapeutic Group Manager PHARMAC PO Box

      12 JulyGeraldine MacGibbon Senior Therapeutic Group Manager PHARMAC PO Box

      Add to Reading List

      Source URL: www.nzma.org.nz

      Language: English - Date: 2016-07-11 21:31:12
      6Turning the Repertoire’s Most Potent Antibodies into Superior Therapeutics  Immuno-Oncology Targets and Therapeutic Antibodies Summary • Theraclone deploys a proprietary platform technology that

      Turning the Repertoire’s Most Potent Antibodies into Superior Therapeutics Immuno-Oncology Targets and Therapeutic Antibodies Summary • Theraclone deploys a proprietary platform technology that

      Add to Reading List

      Source URL: www.theraclone-sciences.com

      - Date: 2015-01-08 11:38:14
        7For a richer research landscape in Leiden  New mouse model, expressing human Fc receptors, to test the efficacy of therapeutic antibodies Key benefits

        For a richer research landscape in Leiden New mouse model, expressing human Fc receptors, to test the efficacy of therapeutic antibodies Key benefits

        Add to Reading List

        Source URL: luris.nl

        Language: English - Date: 2015-04-08 03:57:35
          8DrugPlus international - November 2004 • 0  A novel technology for the production of highly active therapeutic proteins by Dr. Hans Baumeister and Dr. Steffen Goletz

          DrugPlus international - November 2004 • 0 A novel technology for the production of highly active therapeutic proteins by Dr. Hans Baumeister and Dr. Steffen Goletz

          Add to Reading List

          Source URL: www.glycotope.com

          Language: English - Date: 2012-06-20 10:10:40
          9sciFLEXARRAYER Application Note NoPeptide microarrays for epitope mapping of antibodies against hTSHR In order to use antibodies as diagnostic markers for the prediction of both prognosis and therapeutic response

          sciFLEXARRAYER Application Note NoPeptide microarrays for epitope mapping of antibodies against hTSHR In order to use antibodies as diagnostic markers for the prediction of both prognosis and therapeutic response

          Add to Reading List

          Source URL: www.scienion.com

          Language: English - Date: 2014-12-22 07:40:21
          10FOR	
  IMMEDIATE	
  RELEASE	
   	
   Theraclone	
  Sciences’	
  I-­‐STAR™	
  Technology	
  Chosen	
  by	
  Wellcome	
  Trust	
  	
   to	
  Identify	
  Therapeutic	
  Antibodies	
  Against	
  Ebol

          FOR  IMMEDIATE  RELEASE     Theraclone  Sciences’  I-­‐STAR™  Technology  Chosen  by  Wellcome  Trust     to  Identify  Therapeutic  Antibodies  Against  Ebol

          Add to Reading List

          Source URL: www.theraclone-sciences.com

          Language: English - Date: 2015-04-30 08:07:06